martes, 2 de junio de 2026
Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns The late-stage trial has been closely watched
https://www.statnews.com/2026/06/01/abivax-ulcerative-colitis-obefazimod/
By Elaine ChenJune 1, 2026
Elaine Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario